Equity

Share Repurchase Authorization Limit

Amgen Share Repurchase Authorization Limit remained flat by 0.0% to $6.80B in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $6.80B to $6.80B.

Analysis

StatementBalance Sheet Statement
SectionEquity
First reportedQ1 2016
Last reportedQ1 2026Apr 30, 2026
Metric ID: share_repurchase_authorization_limit

Historical Data

15 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$3.90B$2.90B$4.60B$4.60B$4.60B$7.00B$7.00B$7.00B$7.00B$7.00B$7.00B$6.80B$6.80B$6.80B$6.80B
QoQ Change-25.6%+58.6%+0.0%+0.0%+52.2%+0.0%+0.0%+0.0%+0.0%+0.0%-2.9%+0.0%+0.0%+0.0%
YoY Change+17.9%+58.6%+52.2%+52.2%+52.2%+0.0%+0.0%+0.0%-2.9%-2.9%-2.9%+0.0%
Range$2.90B$7.00B
CAGR+17.2%
Avg YoY Growth+18.7%
Median YoY Growth+0.0%
Current Streak3 quarters growth

Share Repurchase Authorization Limit at Other Companies

Frequently Asked Questions

What is Amgen's share repurchase authorization limit?
Amgen (AMGN) reported share repurchase authorization limit of $6.80B in Q1 2026.
How has Amgen's share repurchase authorization limit changed year-over-year?
Amgen's share repurchase authorization limit decreased by 0.0% year-over-year, from $6.80B to $6.80B.